Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
  1. 4 Grant or award See Remarks acquired 63,412 shares (grant or award)
  2. 4 Planned sale Chief Operating Officer sold 90,806 shares at an average $16.63 ($1,509,925)
  3. 4 Planned sale President and CEO sold 100,000 shares at an average $16.56 ($1,656,085)
  4. 4 Grant or award Chief Medical Officer acquired 1,337 shares (grant or award)
  5. 4 Grant or award President and CEO acquired 1,421 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 1,463 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Planned sale Chief Operating Officer sold 4,107 shares at an average $16.01 ($65,755)
  12. 4 Planned sale Chief Operating Officer sold 2,400 shares at an average $16.05 ($38,529)
  13. 4 Planned sale Chief Operating Officer sold 1,903 shares at an average $16.03 ($30,512)
  14. 4 Planned sale Chief Operating Officer sold 40,365 shares at an average $16.70 ($674,246)
  15. 4 Planned sale Chief Operating Officer sold 46,784 shares at an average $16.86 ($788,636)
  16. 4 Planned sale Chief Executive Officer sold 24,190 shares at an average $17.01 ($411,512)
  17. 4 Planned sale Chief Executive Officer sold 75,810 shares at an average $17.12 ($1,297,542)
  18. 4 Planned sale Chief Executive Officer sold 20,700 shares at an average $16.08 ($332,867)
  19. 4 Planned sale Chief Operating Officer sold 18,340 shares at an average $16.11 ($295,405)
  20. 4 Derivatives Options or other derivatives

Page 6 of 11 · 203 filings